Multiple Assemblies exist for SMTL entry 6c4d
Structure based design of RIP1 kinase inhibitors; X-RAY DIFFRACTION 2.52 Å

	SMTL ID 6c4d.1 Ligands (3S)-3-(2-benzyl-3-chloro-7-oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)-5-methyl-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine-8-carbonitrile Polypeptides Receptor-interacting serine/threonine-protein kinase 1 Oligo-state monomer
	SMTL ID 6c4d.2 Ligands (3S)-3-(2-benzyl-3-chloro-7-oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)-5-methyl-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine-8-carbonitrile Polypeptides Receptor-interacting serine/threonine-protein kinase 1 Oligo-state monomer
	SMTL ID 6c4d.3 Ligands (3S)-3-(2-benzyl-3-chloro-7-oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)-5-methyl-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine-8-carbonitrile Polypeptides Receptor-interacting serine/threonine-protein kinase 1 Oligo-state monomer
	SMTL ID 6c4d.4 Ligands (3S)-3-(2-benzyl-3-chloro-7-oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)-5-methyl-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine-8-carbonitrile Polypeptides Receptor-interacting serine/threonine-protein kinase 1 Oligo-state monomer